|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 | |
| A61K 35/28 |
| (11) | Number of the document | 3286562 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16722548.1 |
| Date of filing the European patent application | 2016-04-25 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/059196 |
| Date | 2016-04-25 |
| (87) | Number | WO 2016/170187 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 15382206 | 2015-04-24 | EP |
| (72) |
DE LA ROSA, Olga, ES
DALEMANS, Wilfried, ES
|
| (73) |
TiGenix, S.A.U.,
Parque Tecnol gico de Madrid C/ Marconi, 1, 28760 Tres Cantos (Madrid),
ES
|
| (54) | BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |
| BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |